US Patent Issued to KANDY THERAPEUTICS on Nov. 18 for "Chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814" (Dutch, British Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,260, issued on Nov. 18, was assigned to KANDY THERAPEUTICS Ltd. (Reading, Great Britain).

"Chemical process for making 6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-amine a key intermediate of NT-814" was invented by Marcel Schleusner (Groningen, Netherlands), Massimo Ghizzoni (Groningen, Netherlands) and Ron Lawrence (Stevenage, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a new process for producing compound 2-(3,5-bis(trifluoromethyl)phenyl)-N-(6-chloro-4-(4-fluoro-2-methylphenyl)pyridin-3-yl)-N,2-dimethylpropanamide (Compound IX) which is useful in the manufacture of compound 2-[3,5-Bis(trifluoromethyl)ph...